Evidence map›Paper›PMID 42265293›Full record

ArticleSurgical endoscopy2026

Patient selection, practice patterns, and perioperative outcomes for robotic splenectomy: a contemporary ACS-NSQIP analysis.

Mohammad Saad Farooq, Anish Jona, Gracia Maria Vargas, Russell A Simons, John T Miura, Giorgos C Karakousis, Mark S Etherington

Abstract read
In one paragraph

Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mohammad Saad FarooqDivision of Endocrine and Oncologic Surgery, Hospital of the University of Pennsylvania, 3400 Spruce Street, 4 Maloney, Philadelphia, PA, 19104, USA. Mohammad.farooq@pennmedicine.upenn.edu.ORCID http://orcid.org/0009-0009-8493-6976
Anish JonaDivision of Endocrine and Oncologic Surgery, Hospital of the University of Pennsylvania, 3400 Spruce Street, 4 Maloney, Philadelphia, PA, 19104, USA.
Gracia Maria VargasDivision of Endocrine and Oncologic Surgery, Hospital of the University of Pennsylvania, 3400 Spruce Street, 4 Maloney, Philadelphia, PA, 19104, USA.
Russell A SimonsDivision of Endocrine and Oncologic Surgery, Hospital of the University of Pennsylvania, 3400 Spruce Street, 4 Maloney, Philadelphia, PA, 19104, USA.
John T MiuraDivision of Endocrine and Oncologic Surgery, Hospital of the University of Pennsylvania, 3400 Spruce Street, 4 Maloney, Philadelphia, PA, 19104, USA.
Giorgos C KarakousisDivision of Endocrine and Oncologic Surgery, Hospital of the University of Pennsylvania, 3400 Spruce Street, 4 Maloney, Philadelphia, PA, 19104, USA.
Mark S EtheringtonDivision of Endocrine and Oncologic Surgery, Hospital of the University of Pennsylvania, 3400 Spruce Street, 4 Maloney, Philadelphia, PA, 19104, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRobot-assisted surgery has increasingly been adopted across multiple surgical specialties, demonstrating benefits such as enhanced precision and visualization, and potentially improved outcomes. However, evidence for its use in less common operations, including splenectomy, remains limited. To better understand its use and outcomes, we examined practice patterns and perioperative results of robotic splenectomy in a large, contemporary national cohort.

methodsThe American College of Surgeons - National Surgical Quality Improvement Program database was queried for adult patients who underwent open, laparoscopic, or robotic splenectomy from 2022 to 2023; patient characteristics were categorized by type of surgical approach. Perioperative outcomes for robotic vs. laparoscopic splenectomy were analyzed using univariable and multivariable analyses.

resultsAmong 852 eligible patients that underwent splenectomy, 163 (19%) operations were performed using the robotic approach, while 339 (39.7%) were laparoscopic and 350 (41.1%) were open. The most common indications for robotic splenectomy were benign hematologic conditions (33%), neoplasm/mass/cyst (32%), and splenomegaly (18%). Compared to laparoscopic surgery, robotic splenectomy was associated with longer operative time (152 vs. 130 min, p < 0.001) but shorter length of stay (3.6 vs. 5.2 days, p = 0.010). Notably, there were no significant differences in the proportion of patients experiencing an unplanned conversion to open surgery, postoperative blood transfusions, or other postoperative complications between the robotic and laparoscopic cohorts.

conclusionIn this large contemporary national cohort, robotic splenectomy was safe, with low morbidity, shorter hospitalization, and longer operative times compared to laparoscopic surgery. These findings support the feasibility and safety of robotic splenectomy with appropriate patient selection.

Indexed as

LaparoscopyPatient SelectionPractice Patterns, Physicians'Robotic Surgical ProceduresSplenectomyAdultAgedFemaleHumansLength of StayMaleMiddle AgedOperative TimePostoperative ComplicationsTreatment OutcomeUnited StatesLaparoscopicNSQIPOutcomesRoboticRobotic surgerySplenectomy

Identifiers

PMID42265293
PMCPMC13457338

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.